Treatment choices for older women with primary operable breast cancer and cognitive impairment_ Results from a prospective, multicentre cohort study.pdf (1.19 MB)
Treatment choices for older women with primary operable breast cancer and cognitive impairment: results from a prospective, multicentre cohort study
journal contribution
posted on 2023-06-10, 01:44 authored by Charlene Martin, Anne Shrestha, Jenna Morgan, Michael Bradburn, Esther Herbert, Maria Burton, Annaliza Todd, Stephen Walters, Sue Ward, Geoffrey Holmes, Malcolm ReedMalcolm Reed, Karen Collins, ThompsonG Robinson, Alistair Ring, Kwok-Leung Cheung, othersObjectives The presence of dementia co-existing with a diagnosis of breast cancer may render management more challenging and have a substantial impact on oncological outcomes. The aim of this study was to examine the treatment and outcomes of older women with co-existing cognitive impairment and primary breast cancer. Materials and methods A prospective, multicentre UK cohort study of women aged 70 years or over with primary operable breast cancer. Patients with and without cognitive impairment were compared to assess differences in treatment and survival outcomes. Results In total, 3416 women were recruited between 2013 and 2018. Of these, 478 (14%) had a diagnosis of dementia or cognitive impairment, subcategorised as mild, moderate and severely impaired. Up to 85% of women with normal cognition underwent surgery compared to 74%, 61% and 40% with mild, moderate, and severe impairment (p = 0.001). Among women at higher risk of recurrence, the uptake of chemotherapy was 25% for cognitively normal women compared to 20%, 22% and 12% for mild, moderate and severe impairment groups (p = 0.222). Radiotherapy use was similar in the subgroups. Although patients with cognitive impairment had shorter overall survival (HR: 2.10, 95% CI: 1.77–2.50, p < 0.001), there were no statistically significant differences in breast cancer specific or progression-free survival. Conclusion Cognitive impairment appears to play a significant part in deciding how to treat older women with breast cancer. Standard treatment may be over-treatment for some women with severe dementia and careful consideration must be given to a more tailored approach in these women.
History
Publication status
- Published
File Version
- Published version
Journal
Journal of Geriatric OncologyISSN
1879-4068Publisher
ElsevierExternal DOI
Issue
5Volume
12Page range
705-713Event location
NetherlandsDepartment affiliated with
- Clinical and Experimental Medicine Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2021-11-15First Open Access (FOA) Date
2021-11-15First Compliant Deposit (FCD) Date
2021-11-12Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC